Investigating how Zhx2 affects oxycodone metabolism and addiction behaviors.
The role of Zhx2 in CYP2D regulation, oxycodone metabolism, and opioid addiction model behaviors.
This study is looking at how certain genes, especially the Zhx2 gene, might affect how people use and respond to oxycodone, a common pain medication, to help understand opioid use disorder better.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10911775 on NIH RePORTER |
What this research studies
This research explores the genetic factors influencing opioid use disorder (OUD), particularly focusing on the role of the Zhx2 gene in the metabolism of oxycodone, a commonly prescribed opioid. By using rodent models, the study aims to identify genetic variants that contribute to behaviors associated with opioid use and misuse. The researchers will employ advanced techniques such as genome-wide association studies and quantitative trait locus mapping to uncover the underlying genetic mechanisms. This approach allows for controlled experiments that can directly validate the impact of specific genes on opioid-related behaviors.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with a history of opioid use or those at risk for opioid use disorder.
Not a fit: Patients who do not have a history of opioid use or are not at risk for opioid use disorder may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for individuals struggling with opioid addiction.
How similar studies have performed: Previous research has shown promise in identifying genetic factors related to opioid addiction, suggesting that this approach could yield valuable insights.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Lynch, William — Boston University Medical Campus
- Study coordinator: Lynch, William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.